The Trump administration is hinting at an upcoming rule aimed at implementing the President’s “most favored nation” drug pricing policy.
The prospect of Lundbeck and Otsuka’s Rexulti becoming part of a new treatment for post-traumatic stress disorder (PTSD) appears more unlikely after a Friday meeting of experts...